Indivisible Partners’s iShares Biotechnology ETF IBB Stock Holding History

Indivisible Partners’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1M	Buy	+4,764	New	+$956K	0.05%	285

Other funds holding IBB

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

WestEnd Advisors Charlotte, North Carolina $4.53B AUM 12.98% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Indivisible Partners's IBB Position: Q3 2026 in Review

Indivisible Partners opened a new position in iShares Biotechnology ETF (IBB) in Q3 2026: 4,764 shares worth $1M. The stake represents 0.05% of the portfolio and ranks #285 among its holdings.

700 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

Indivisible Partners held 4,764 shares of iShares Biotechnology ETF worth $1M as of Q3 2026.
iShares Biotechnology ETF was a new Indivisible Partners position in Q3 2026.
iShares Biotechnology ETF made up 0.05% of Indivisible Partners's portfolio in Q3 2026, its #285 holding.
700 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Indivisible Partners's 13F filing for Q3 2026, filed 26 Oct 2026.